Category Archives: Government

FDA warns against unproven medical claims for marijuana. “Prohibition” didn’t work, remember?

The News: Four companies selling dozens of various marijuana-derived dietary supplements have been officially warned by the US Food and Drug Administration to stop plugging their products as cures for… Read more »

Fancy this: Pharma gifts to docs still paying off–big time.

The News: Giving someone a box of donuts may seem like a harmless gesture, but for pharmaceutical companies it could boost sales. A new study of healthcare providers in the… Read more »

McConnell willing to hold Senate vote on bipartisan health deal if Trump endorses, but what are the odds of passage?

The News: Senator Mitch McConnell of Kentucky, the majority leader, said on Sunday (October 22, 2017) that he would be willing to bring a bipartisan proposal to stabilize health insurance… Read more »

Trump does end-run around Congress, scraps Obamacare insurer subsidies via executive order; what’s really happening?

The News: An alliance of US states joined ranks on Friday (October 13, 2017) to sue to block President Donald Trump’s move to dump a key component of Obamacare–subsidies to… Read more »

China’s FDA to accept foreign trial data for accelerated approvals; sounds great, but future enforcement of IP rights poses threat to US Pharma.

The News: For decades, patients in China have fought to gain access to cutting-edge medicines thanks to bureaucratic delays that have thwarted drug development. Now a sweeping government overhaul of… Read more »

FDA’s Gottlieb continues to amaze, turning agency into pharma-friendly ally.

The News: The US Food and Drug Administration on Monday (October 2, 2017) announced a series of measures designed to speed to market generic versions of complex drugs such as… Read more »

Senators seek probe of Allergan’s patent sale to Mohawk Tribe; could Tesla do the same with its battery patents?

The News: Four senators are demanding an investigation of Allergan PLC’s (Dublin IRL) first-of-a-kind patent deal with the Saint Regis Mohawk Tribe, alleging the move to protect Restasis is another… Read more »

Patients lose, lawyers win, as AbbVie does deal with Amgen to delay Humira biosim.

The News: Amgen Inc. (Thousand Oaks CA) has agreed to delay the US launch of its FDA-approved biosimilar version of AbbVie Inc.’s (North Chicago) Humira (adalimumab) until 2023, under a… Read more »

McConnell scraps Graham-Cassidy bill; but be mindful of Yogi Berra’s quip back in 1973.

The Latest: Senate Republican leaders on Tuesday (September 26, 2017) officially pulled the plug on the latest plan to repeal the Affordable Care Act, abandoning a planned vote on the… Read more »